A prospective multicentre controlled study of Gaoweikang (Chinese multiherb extract-based tincture) used in high-risk HPV infections.

医学 内科学 B组 前瞻性队列研究 酊剂(纹章学) 胃肠病学 外科 传统医学
作者
Chen Lm,Cong Qi,Deqing Wu,Pei‐Jer Chen,Lugui Qiu,Zhi-Jie Hong,Ying Yang,Xu Liu,Wang Lf,Li Huang,W-R Li,Jiyu Tang,Yongli Cao,Lu-Lu Sui
出处
期刊:PubMed [National Institutes of Health]
卷期号:27 (19): 8985-8992
标识
DOI:10.26355/eurrev_202310_33922
摘要

The aim of the study was to investigate the safety and antiviral efficacy of a Chinese multiherb extract-based tincture (GWK) on a population of patients with high-risk human papilloma (hrHPV) infections and hrHPV-caused cervical low-grade squamous intraepithelial lesions (LSILs).Patients with persistent hrHPV infection were enrolled in Group A, including A1 subjects, who received the intervention, and A2 subjects, who received the control. Patients with hrHPV infection causing cervical LSIL were enrolled in Group B, which included B1 subjects, who received the intervention, and B2 subjects, who served as the control. For Groups A1 and B1, hrHPV was tested at 3 months (M3) and 6 months (M6) after the intervention. The side effects were also analyzed.At baseline (D0), a total of 99 patients were enrolled in Group A, with 50 subjects in Group A1 and 49 subjects in Group A2. A total of 91 patients were enrolled in Group B, with 45 subjects in Group B1 and 46 subjects in Group B2. There was no significant difference in the characteristics, including average age, age stratification, and HPV genotype. At M6, both Group A1 and Group B1 had a higher hrHPV clearance rate than the control group (A1/A2: 80.0% vs. 20.4%; B1/B2: 64.4% vs. 15.2%, p<0.001). At M6, the effective rates of Group A1 and Group B1 were 84% (42/50) and 68.9% (31/45), respectively. The side effect rates of Groups A1 and B1 were 11.5% (6/52) and 11.1% (5/45), respectively. Most adverse reactions involved local discomfort, including vulvar erythema, vulvar itch, increased vaginal discharge, cervical bleeding, and mild pain in the lower abdomen. Univariate logistic regression analysis showed that the intervention had an OR of 12 (95% CI 4.431-32.50) for clearing persistent HPV infection (p<0.001). For cervical LSIL, the intervention had an OR of 10.1 for clearing persistent HPV infection (95% CI 3.68-27.7) (p<0.001).The results of this study suggest that the Chinese multiherb extract-based tincture GWK is safe and well tolerated. Furthermore, this preliminary study showed that this Chinese multiherb extract-based tincture is helpful for promoting HPV clearance in cases of persistent HPV and HPV-induced LSIL.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ale应助wang采纳,获得20
刚刚
unowhoiam发布了新的文献求助10
刚刚
Songing发布了新的文献求助10
1秒前
xie完成签到,获得积分10
1秒前
Ning完成签到,获得积分10
1秒前
1秒前
2秒前
2秒前
2秒前
蓝天发布了新的文献求助10
2秒前
小马甲应助灵巧的朝雪采纳,获得10
2秒前
2秒前
zhuojiu发布了新的文献求助10
3秒前
坦率续发布了新的文献求助10
3秒前
小蘑菇应助lulu采纳,获得10
3秒前
ykh发布了新的文献求助10
3秒前
3秒前
xymy发布了新的文献求助10
4秒前
李健的小迷弟应助Gracywss采纳,获得10
4秒前
NiL发布了新的文献求助10
4秒前
1010完成签到,获得积分10
6秒前
闪电鼠发布了新的文献求助10
7秒前
852应助ATUMU采纳,获得10
7秒前
两条鱼发布了新的文献求助10
8秒前
zhanghezheng完成签到,获得积分10
9秒前
10秒前
10秒前
JamesPei应助kk2024采纳,获得10
10秒前
咿呀咿呀哟应助painting采纳,获得10
10秒前
10秒前
11秒前
11秒前
酷波er应助无忆采纳,获得10
11秒前
碎觉觉发布了新的文献求助20
12秒前
12秒前
13秒前
NexusExplorer应助失眠芷蕊采纳,获得10
14秒前
坦率续完成签到,获得积分10
14秒前
CodeCraft应助mhhhd采纳,获得10
14秒前
CipherSage应助sailingray采纳,获得10
15秒前
高分求助中
Markov Chain Monte Carlo 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Common Foundations of American and East Asian Modernisation: From Alexander Hamilton to Junichero Koizumi 1500
Advanced Weaponeering Fourth Edition, Volume 2 1000
悉尼大学博士学位论文,题目:Modelling and testing of one-sided stitched laminated composites. 作者:Kristopher P. Plain 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 610
Curating Socialism: A Handbook of International Art Exhibitions 1947-1989 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7509846
求助须知:如何正确求助?哪些是违规求助? 9098486
关于积分的说明 19418007
捐赠科研通 7116722
什么是DOI,文献DOI怎么找? 3252722
关于科研通互助平台的介绍 2421584
邀请新用户注册赠送积分活动 2238928